SNDA (45) ARDT (67) MD (74) BKD (46) ⌘ Pro Terminal →

Healthcare Services Group Inc. (HCSG) — RQD Stock Rating Cockpit

$24.68 +2.58% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $24.85

Healthcare Services Group Inc. (HCSG) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (13% profit margin, 12% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate) →

ROARABLE B- • BUY Cap $1.66B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $24.85 (+0.70%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 7.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 70/100 (B-) historically ranked in the Top 15% of excess returns over the next 90 days (+6.6% avg 90D alpha vs SPY • 68.1% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B- · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HCSG)Realized 20D OHLCV Swing Band: ±7.7%

Deterministic 5-Pillar Attribution (70/100 Composite)

🔍 WHY HCSG SCORES 70/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 7.6% FCF Margin ($139.2M FCF) & 13% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (21% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Whale & Options Positioning11/20 pts (-9 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-9 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C+$20.59+2.6% Next Q

Q2 (-2Q)

Grade C+$21.13+19.7% Next Q

Q3 (-1Q)

Grade B-$25.30-2.5% Next Q

Current

Grade B-$24.68+6.6% Hist 90D α

Trajectory: C+ (62) → B- (70)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HCSG Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 70/100 (B-) score, HCSG faces multiple-compression risk if 28.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 15.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($21.97) or 200D SMA ($21.40) invalidates the momentum regime and cuts Target Base ($26.01) toward Bear Floor ($20.24).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HCSG• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HCSG Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 70%NO 30%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

67.330 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE88% OF RANGE

L: $17$24.68H: $26

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (13% profit margin and healthy balance-sheet cushion).

Factor Grade: B+RQD 16 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40

3. Hidden Risks & Market Weather● ALL CLEAR

SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: B-RQD 28 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bullish on HCSG

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (80)

11.6% ROIC with 13.0% gross margin and 8.36% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (75)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (65)

26/40 institutional & smart-money positioning score with 13/20 macro alignment.

Bull Case: Why Buyers Like HCSG

✓Strong cash generator (13% profit margin)—profits are backed by real money, not accounting tricks.
✓Company leadership has skin in the game with net positive insider conviction.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Broader market pullbacks can still drag down strong stocks in the short run.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HCSG Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HCSG // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +15.27%📐 HORIZONTAL RANGE

2026-10-30O $24.93H $25.09L $24.36C $24.68VOL 635.0K

RES: $25.68SUP: $19.91SMA50: $21.97SMA200: $21.40

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HCSG Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HCSG Butterfly Map → + Track HCSG →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

21.6%/yr Implied 5Y Growth

vs. +7.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HCSG today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HCSG. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HCSG today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HCSG)

Health Care Rank #93 of 1016 ⚔️ SNDA vs HCSG Full Matrix →

1. Head-to-Head Health Care Peer Comparison (HCSG vs. SNDA, ARDT, MD, BKD)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Healthcare Services Group Inc. (HCSG) ranks #93 by composite RQD confidence (70/100, grade B-) and #292 by equity capitalization ($1.66B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with HCSG at 70/100 (B-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HCSG ACTIVE Healthcare Services Group Inc.	B-	70/100	28.2x	13.0%	11.6%	+2.58%	$1.66B	Benchmark Subject
SNDA Sonida Senior Living Inc.	D	45/100	—	—	—	+1.94%	$1.65B	/snda-vs-hcsg →
ARDT Ardent Health Inc.	C+	67/100	12.8x	—	10.5%	+3.10%	$1.73B	/ardt-vs-hcsg →
MD Pediatrix Medical Group Inc.	B	74/100	14.3x	—	33.6%	+0.93%	$2.37B	/md-vs-hcsg →
BKD Brookdale Senior Living Inc.	D	46/100	—	26.2%	0.3%	+2.91%	$2.45B	/bkd-vs-hcsg →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000731012

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Healthcare Services Group Inc. (HCSG) reported GAAP revenue of $1.84B (+7.1% vs. FY2024 revenue of $1.72B , and +9.9% cumulative change since FY2023) , GAAP net income of $59.1M, operating cash flow of $145.0M, and free cash flow of $139.2M (+468.7% YoY). On the balance sheet, HCSG closed FY2025 with $794.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.84B	$59.1M	$145.0M	$139.2M	$794.3M	—
FY2024 (FY)	2024-12-31	$1.72B	$39.5M	$30.8M	$24.5M	$802.8M	—
FY2023 (FY)	2023-12-31	$1.67B	$38.4M	$43.5M	$43.5M	—	—

3. HCSG Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HCSG stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Healthcare Services Group Inc. (NASDAQ: HCSG) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 70/100 at a spot price of $24.68 (+2.58% 1D, market cap $1.66B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 15/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, HCSG ranks #93 in composite RQD confidence.

How does HCSG compare to SNDA and ARDT in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), HCSG carries a Roarable B- (70/100 RQD), trailing P/E of 28.2x, gross margin of 13.0%, and ROIC of 11.6%. By comparison, SNDA (Sonida Senior Living Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $1.65B) and ARDT (Ardent Health Inc.) posts a C+ grade (67/100 RQD, P/E 12.8x, ROIC 10.5%, cap $1.73B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HCSG?

Per HCSG's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000731012), Healthcare Services Group Inc. generated $1.84B in revenue (+7.1% YoY), $59.1M in net income, and $139.2M in free cash flow against $794.3M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (13% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HCSG trading relative to its 50-day, 200-day, and 52-week technical levels?

HCSG last traded at $24.68 (+2.58% on volume of 712,895 shares), positioning the stock +12.34% above its 50-day simple moving average ($21.97) and +15.33% above its 200-day simple moving average ($21.40). Across its 52-week range of $16.78 to $25.75, HCSG sits at the 88.1% percentile with a 14-day RSI of 67.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.7% ($22.78 to $26.58).

HCSG Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell HCSG stock right now?

Healthcare Services Group Inc. (HCSG) currently earns a Roarable Rating of B- (Buy — BUY) with 70/100 RQD Confidence. High-quality cash engine (13% profit margin, 12% return on capital) with steady institutional support.

What is HCSG's 12-month price target and RQD AI Jury consensus?

HCSG's 12-month base price target is $26.01 (range $20.24 to $30.69), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: HCSG RQD Cockpit HCSG 12M Forecast HCSG Earnings & Move HCSG Dividends & DRIP HCSG Insiders & 13F HCSG Whale Options HCSG Profit Sankey HCSG News & Why